Abilify | The American Association For Justice



Abilify is a widely prescribed, atypical, anti-psychotic prescription medicine developed and marketed by Bristol-Myers Squibb Company, Otsuka Pharmaceutical Co., Ltd, and various Otsuka subsidiaries. In many patients, Abilify causes uncontrollable compulsive behaviors such as compulsive gambling. The manufacturers warn about this side effect in Europe and Canada but not in the United States. Internal company documents acknowledge a plausible biological mechanism based on the long-known relationship of dopamine (upon which Abilify acts in the brain) and compulsive gambling. 

Benefits & Resources:

The Litigation Group will educate members about Abilify and keep them apprised of the status of litigation through litigation group meetings, the group’s list server, and the sharing of materials.

Ernest Cory                            
Cory Watson, PC
2131 Magnolia Ave., Second Fl.
Birmingham, AL 35205
Phone: 205/328-2200
Marlene J. Goldenberg
GoldenbergLaw, PLLC
800 LaSalle Ave. Suite 2150
Minneapolis, MN 55402
Phone: 612/308-5661
Gary Wilson
Robins Kaplan LLP
2800 Lasalle Plz.
800 Lasalle Ave.
Minneapolis, MN 55402
Phone: 612/349-8500
PDF Application:
$300 annually